tradingkey.logo

Monogram Technologies Inc

MGRM
View Detailed Chart

5.840USD

+0.070+1.21%
Close 09/19, 16:00ETQuotes delayed by 15 min
210.76MMarket Cap
LossP/E TTM

Monogram Technologies Inc

5.840

+0.070+1.21%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.21%

5 Days

+1.57%

1 Month

+10.40%

6 Months

+73.81%

Year to Date

+146.41%

1 Year

+105.63%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
77 / 207
Overall Ranking
176 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 1 analysts
Buy
Current Rating
8.400
Target Price
+45.58%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 20.36.
Undervalued
The company’s latest PE is -10.86, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 13.82M shares, increasing 1.15% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 1.00M shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.44.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
Ticker SymbolMGRM
CompanyMonogram Technologies Inc
CEOMr. Benjamin Sexson
Websitehttps://www.monogramtechnologies.com/
KeyAI